The role of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis and the influence on ovarian function
Non-randomised trial
OA: closed
CC0
AI-generated summary
The levonorgestrel-releasing intrauterine system effectively reduced menorrhagia and dysmenorrhea in adenomyosis patients by down-regulating endometrial estrogen and progesterone receptors while preserving ovarian function.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective:To evaluate the efficacy of a LNG-IUS for the treatment of menorrhagia,dysmenorrheal associated with adenomyosis and the influence of ovarian function.Methods:40 cases with menorrhagia and dysmenorrheal were treated with LNG-IUS.The menstrual blood loss and dysmenorrheal were observed in pre-and post-insertion of LNG-IUS at 3,6,12 months respectively.ER and PR expression in the endometrium by immunohistochemical methods,serum-levels of FSH,LH and E2 were tested in pre-and post-insertion at 6,12 months respectively.Results:38 women complete the study.There were significant differences between PBAC Score of menstrual blood and VRS Scores changes of menorrhagia and dysmenorrheal at baseline and 3,6,12 months follow-up.Those of menstrual blood dropping from 120.6±61.3 to 53.1±21.8,39.6±19.8,17.6±6.7;Those of dysmenorrheal dropping from 2.2±0.6 to 1.5±0.6,0.8±0.6,0.5±0.3.Expressions of ER and PR were down-regulated significantly after treatment.(P 〈0.01).Conclusion:LNG-IUS is an effective therapy in the treatment of menorrhagia and dysmenorrheal associated with adenomyosis,with little effect on ovarian function.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK